Patient selection
Study participants were recruited from the Department of Operative Dentistry, Dow University of Health Sciences during November 2017 to October 2019. The study protocol was approved by Institutional Review Board, Dow University of Health Sciences (Ref: IRB-862/DUHS/Approval/2017/50). Informed consent was taken from all patients before initiating the treatment.
Participants aged between 15-57 years, presenting with chronic apical periodontitis or chronic apical abscess of an anterior tooth with previously attempted or failed root canal treatment, radiographically shown as radiolucency around the root apex (greater than 4 mm) with the loss of lamina dura, periodontal ligament space and patients with persistent periapical lesion developing in a single-rooted tooth that has encountered trauma before root closure were enrolled in this study. A total of 35 patients who met the inclusion criteria of the study were initially included in the study. However, 8 patients were lost to follow-up, and hence the study was conducted on 27 participants. Medically compromised patients with any uncontrolled systemic disease or ASA Level III, multi-rooted teeth, single-rooted teeth with less than 4 mm periapical lesion, and patients with pre-existing conditions such as periodontal disease, and pregnant or lactating women were excluded from the study.
Treatment protocol and tissue retrieval
A preoperative digital periapical radiograph was taken with cone indicator and reference marker, placed over the sensor. Conventional re-root canal treatment was performed, and patients were scheduled for periapical endodontic surgery. Local anaesthesia 1:80,000 lidocaine with epinephrine was administered and a full thickness mucoperiosteal flap was elevated. After identifying the periapical lesion site, a window was created by removing the cortical bone with a small round bur #2 (Mani, Japan) in a slow-speed handpiece. The periapical lesion was removed with the help of curettes (Hilbro, Japan). Apicoectomy and retrograde cavity preparation was performed with the help of ultrasonic tips (Pro ultra, DENTSPLY Maillefer, Switzerland) and the retrograde filling was done with MTA (Pro-root MTA, DENTSPLY Tulsa Dental Specialties, USA). The flap was then repositioned and sutured with a 3/0 silk suture (ETHICON, LLC).
Tissue from the periapical lesion was collected and divided immediately into two fragments: one fragment was transferred in RNA later buffer filled 1.5mL sterilized centrifuge tubes and kept in -80°C until homogenized to extract RNA, the second fragment was used for histopathological analysis.
Tissue processing for histopathological analysis:
After removal from the root apex, the adhering diseased tissues were immediately stored in 10% buffered formalin until histopathological analysis. Each lesion tissue was then placed in a tissue processor (PT09, Lupetec, Sao Carlos, SP, Brazil) where they were treated with increasing concentration of ethanol, proceeded with xylol before being embedded in paraffin. Later these paraffin blocks were cut into 5-µm sections for histopathological examination. During deparaffinization, the 5-µm sections were treated with two sequences of xylol, hydrating in decreasing concentration of ethanol, and washed with tap and distilled water before placing it in hematoxylin for 3 mins. The sections were then washed in tap water for 15 mins followed by immersion into 70% ethanol and then keeping it in eosin for 5 mins. Lastly, the samples were immersed in absolute ethanol four times and three times in xylol before being mounted by coverslip using Enthelan® (Merck, Darmstadt, Germany). Microscopic analysis of the hematoxylin-eosin-stained slides was performed using a Nikon Eclipse E200 optical microscope (Nikon Instruments Inc., Tokyo, Japan). Only the lesions classified as Periapical Granuloma were included in this study. The periapical granuloma was identified as granulation tissues surrounded by fibrous connective tissues showing the presence of macrophages, lymphocytes, plasma cells, giant cells, fibroblasts, and masts cells.
Tissue processing for RNA extraction and cDNA synthesis
Total RNA was purified from each of the frozen periapical granuloma tissue using bead mill homogenization as per the manufacturer’s instructions. The tissue was weighed out in 2mL centrifuged tube already containing 0.4g of 0.5mm glass beads and 1% β-mercaptoethanol containing 500µL of RLT Buffer (Qiagen, Hilden, Germany). The tube was then subjected to the bead mill homogenization process in Omni bead ruptor 24 (Omni International, Kennesaw, GA, USA). Total RNA was then purified from homogenate using RNeasy Mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. RNA concentration and purity were quantified by nanodrop and aliquoted to save at -80°C until further use.
RNA was reverse transcribed by using an M-MLV reverse transcriptase kit (Promega, Madison, WI, USA). RNA template (5µL) was mixed with 1µL OligodT (0.5µg/µL), 1µL dNTPs 10µM and 8µL Nuclease free water and was incubated on the preheated block at 65°C for 5min. At the end of incubation, the reaction mixture was immediately chilled on ice for 5min then briefly spin to bring the contents down to the bottom of the tube. This reaction was combined with a reaction mixture containing 4µL M-MLV RT 5x reaction buffer and 1µL M-MLV Reverse transcriptase (10,000U) to make the volume up to 20µL. This reaction mixture was incubated at 50°C for 30 minutes, 85°C for 5 min, and 4°C for hold in Eppendorf (Hamburg, Germany) thermal cycler.
Quantitative Polymerase Chain Reaction for metalloprotease genes
cDNA samples were used to perform quantitative-PCR (qPCR) to measure the expression levels of MMP -1, -2, -7, and -9 genes. β-actin served as a housekeeping gene and was also used to normalize the results in a qPCR using respective primer sets. A list of primers used to measure the levels of MMP, and β-actin is given in Table 1.
Table 1: Name of target genes and respective primer sets used to quantify mRNA levels in qPCR.
Gene
|
Forward Primer (5’ to 3’)
|
Reverse Primer (5’ to 3’)
|
Β-actin
|
GCGCGGCTACAGCTTCA
|
CTCCTTAATGTCACGCACGAT
|
MMP1
|
AAAATTACACGCCAGATTTGCC
|
TGTTGGTCCACCTTTCATCTTC
|
MMP2
|
TACAGGATCATTGGCTACACACC
|
GGTCACATCGCTCCAGACT
|
MMP7
|
GAGTGAGCTACAGTGGGAACA
|
CTATGACGCGGGAGTTTAACAT
|
MMP9
|
TGTACCGCTATGGTTACACTCG
|
GGCAGGGACAGTTGCTTCT
|
For qPCR analysis, a 20uL reaction mixture was prepared using the following recipe: 2uL of cDNA, 0.6µL (10pmol/µL) of forward and reverse primers, and 10uL of Evergreen qPCR master mix (ABM, Canada). The qPCR reaction was run on CFX96™ Real-Time PCR System (BIO-RAD, USA), using thermocycling protocol: 10 min at 95°C, 40 cycles of 15 s at 95°C and 30 s at 57°C. Only four samples, which had low total RNA concentrations, were allowed to run up to 60 cycles. Melt curve (55°C-95°C) analysis was performed at the end of 40/60 cycles to verify the identity of PCR products. All reactions were run in triplicate. The relative gene expression was calculated using the following formula:
Relative % gene expression: A/B x 100
where, A = average Ct for housekeeping gene, B = average Ct for the gene of interest (MMPs).
In the next step, we applied ANOVA with Tukey's multiple comparison test to determine the significant difference in relative gene expression between all tested MMPs in healer and non-healer, where p<0.05 was considered as a statistically significant value.